Aiwen D.

Aiwen D. currently serves as Associate Director of Translational Medicine at Exelixis since March 2022. Previously, Aiwen D. held the roles of Principal Scientist and then Director of Molecular Oncology at Riboscience from March 2016 to March 2022. Before that, Aiwen D. was a Postdoctoral Research Fellow and later a Staff Scientist at Stanford University from May 2008 to February 2016. Aiwen D. completed a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology at the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, from September 2002 to March 2008, and served as a Visiting Research Scholar at Universidad de Navarra from April 2004 to January 2008. Aiwen D. also completed postdoctoral training in Oncology and Cancer Biology at Stanford University School of Medicine from January 2008 to December 2012.